Quiet Bull

Quiet Bull

Home
Notes
Chat
Archive
About
Intellia Therapeutics (NTLA): A Quiet Bull Deep Dive
July 27, 2026
Jul 27 • Quiet Bull
5:50
Quiet Bull Index (QBI) Weekly Update | AI Leads, Biotech Waits | Week Ending July 26, 2026
July 26, 2026
Jul 26 • Quiet Bull
2:18
QBI Weekly Update | Leadership Rotates, Opportunity Emerges | July 20, 2026
July 20, 2026
Jul 25 • Quiet Bull
2:40
IOVA Deep Dive: Is Iovance Biotherapeutics a Buy Under $5 | Quiet Bull
July 15, 2026
Jul 25 • Quiet Bull
1:11
Quiet Bull Index (QBI) | Our High-Conviction Names & Long-Term Themes
July 15, 2026
Jul 25 • Quiet Bull
1:07
IBM Shocks the Market | Why IBM Fell 25% in One Day
July 14, 2026
Jul 25 • Quiet Bull
0:15
NVAX Deep Dive | Why Zacks Upgraded Novavax to Strong Buy
July 14, 2026
Jul 25 • Quiet Bull
1:45
XBI Technical Analysis | Is Biotech Entering a New Bull Market? (Weekly, Monthly & Quarterly)
July 13, 2026
Jul 25 • Quiet Bull
0:30
QB Conviction Board | Our 10 Highest Conviction Names | July 2026
July 13, 2026
Jul 25 • Quiet Bull
1:59
Feedback | July 12, 2026
July 12, 2026
Jul 25 • Quiet Bull
0:07
Catalyst-15 Update | The Future of Human Health | July 2026
July 11, 2026
Jul 25 • Quiet Bull
3:18
QBI Weekly Update | AI Leads, Biotech Weakens | Week Ending July 10, 2026
July 11, 2026
Jul 25 • Quiet Bull
3:13
© 2026 Quiet Bull · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture